Day: September 10, 2026

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health’s Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

DiagnosTear Announces Positive Final Results from Clinical Study Demonstrating Strong Diagnostic Performance of TeaRx(TM) Red Eye for Detecting Total Tear IgE as a Biomarker for Allergic conjunctivitis

Final study results demonstrate 89% sensitivity, 83.3% specificity compared with quantitative ELISA reference testing for IgE detection.Vancouver, British Columbia--(Newsfile Corp....

Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate

Filament Health has begun planning a stability program for IBEX011, its naturally derived botanical ibogaine drug candidate, in response to...

error: Content is protected !!